A qualitative and quantitative evaluation of parkinsonians three to six years following thalamotomy.
D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005500:Follow-Up Studies; D006801:Humans; D009048:Motor Skills; D009127:Muscle Rigidity; D010300:Parkinson Disease / Q000188:drug therapy / Q000601:surgery*; D013064:Speech Disorders; D013788:Thalamus / Q000601:surgery*; D014202:Tremor
D004295:Dihydroxyphenylalanine